With concerns over the Canadian launch of GIOTRIF due to the unfavourable adverse events (AEs) profile, our team created a patient first approach.
In collaborating with patients, KOLs, nurses, and allied health care professionals, a patient focused approach that extended beyond the medication and the financial component was discovered.
Our team proactively worked to mitigate the frequency of severe AEs by creating an armamentarium of tools to bring treatment directly to the patient on day one, including: a mail order system for GIOTRIF, in-home nurse visitation, a patient mobile app, an HCP diagnostic app, and creative branding and trademarking.
As the creative lead, I led the team in the development of branding and execution of tools that have been historically disjointed in print, to a single omni-channel experience for the patient right from diagnosis with the HCP diagnostic app to management of their disease using a mobile patient app.
In collaborating with patients, KOLs, nurses, and allied health care professionals, a patient focused approach that extended beyond the medication and the financial component was discovered.
Our team proactively worked to mitigate the frequency of severe AEs by creating an armamentarium of tools to bring treatment directly to the patient on day one, including: a mail order system for GIOTRIF, in-home nurse visitation, a patient mobile app, an HCP diagnostic app, and creative branding and trademarking.
As the creative lead, I led the team in the development of branding and execution of tools that have been historically disjointed in print, to a single omni-channel experience for the patient right from diagnosis with the HCP diagnostic app to management of their disease using a mobile patient app.
